Adriann Sax
Directeur Général chez Vetigenics LLC
Fortune : - $ au 30/04/2024
Profil
Adriann W.
Sax is the founder and currently serves as the Chief Executive Officer of Vetigenics LLC, a company founded in 2020.
Prior to founding Vetigenics LLC, Sax holds the position of Chief Executive Officer & Director at Orsenix LLC from 2019 to 2020.
Sax also has experience as an Executive Director-Oncology at Merck & Co., Inc., Director at Healthcare Businesswomens Association, Independent Director at QSAM Biosciences, Inc. from 2022 to 2024, Vice President-Marketing at Bristol Myers Squibb Co., EVP-Business Development & Strategic Planning at KP Pharmaceuticals LLC, Principal at Sterling Drug, Inc., Chief Business Officer at Symphogen A, Principal at Roche Laboratories, Inc., and Chief Commercial Officer & Executive VP at Kadmon Corp.
LLC.
Sax's education includes an undergraduate degree from the University of Delaware and an MBA from Keller Graduate School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
-.--% | 02/05/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Adriann Sax
| Sociétés | Poste | Début |
|---|---|---|
Vetigenics LLC
 Vetigenics LLC Pharmaceuticals: MajorHealth Technology Vetigenics LLC is a clinical-stage animal health biopharmaceutical company based in Philadelphia, PA. Vetigenics LLC is committed to advancing targeted antibody therapies for pets using its proprietary canibody™ technology. Vetigenics' innovative technology and expertise in antibody discovery and development are trusted by animal health partners and the National Cancer Institute. Vetigenics is dedicated to enabling pets to live their best lives. The company was founded by Adriann W. Sax, Don Siegel, and Nicola Mason, with Adriann W. Sax serving as the CEO since incorporation. | Directeur Général | 01/05/2020 |
Anciens postes connus de Adriann Sax
| Sociétés | Poste | Fin |
|---|---|---|
| QSAM BIOSCIENCES, INC. | Directeur/Membre du Conseil | 02/05/2024 |
| Orsenix LLC | Directeur Général | 01/01/2020 |
Kadmon Corp. LLC
 Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Kadmon Corp. LLC manufactures and distributes pharmaceutical products. It currently offers products and services for the treatment and management of hepatitis C, is pioneering medicines in oncology, infectious diseases, and immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. The company was founded in 2009 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
| Sterling Drug, Inc. | Corporate Officer/Principal | - |
Healthcare Businesswomens Association
 Healthcare Businesswomens Association Miscellaneous Commercial ServicesCommercial Services Healthcare Businesswomens Association operates women healthcare associations. The company was founded by Diane Anderson, Peg Dougherty, Millicent Gryczka, Sheila Sinkking and Ruth Smith in 1977 and is headquartered in Fairfield, NJ. | Directeur/Membre du Conseil | - |
Formation de Adriann Sax
| University of Delaware | Undergraduate Degree |
| Keller Graduate School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| MERCK & CO., INC. | Health Technology |
| Entreprise privées | 9 |
|---|---|
KP Pharmaceuticals LLC
 KP Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology KP Pharmaceuticals LLC is a pharmaceuticals company which develops, manufactures, markets and sells branded prescription pharmaceutical products. The company was founded by John M. Gregory, Randal J. Kirk, Joseph R. Gregory, Jefferson J. Gregory and James E. Gregory in 1993 and is is headquartered in Bristol, TN. | Health Technology |
Healthcare Businesswomens Association
Healthcare Businesswomens Association Miscellaneous Commercial ServicesCommercial Services Healthcare Businesswomens Association operates women healthcare associations. The company was founded by Diane Anderson, Peg Dougherty, Millicent Gryczka, Sheila Sinkking and Ruth Smith in 1977 and is headquartered in Fairfield, NJ. | Commercial Services |
| Sterling Drug, Inc. | Consumer Non-Durables |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Health Technology |
Roche Laboratories, Inc.
 Roche Laboratories, Inc. Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Laboratories, Inc. markets and sells pharmaceutical medications. The company is based in Nutley, NJ. | Distribution Services |
Kadmon Corp. LLC
Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Kadmon Corp. LLC manufactures and distributes pharmaceutical products. It currently offers products and services for the treatment and management of hepatitis C, is pioneering medicines in oncology, infectious diseases, and immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. The company was founded in 2009 and is headquartered in New York, NY. | Health Technology |
QSAM Biosciences, Inc.
 QSAM Biosciences, Inc. Chemicals: AgriculturalProcess Industries QSAM Biosciences, Inc. engages in the provision of nuclear medicines for the treatment of cancer and related diseases and conditions. It also focuses on the development of its licensed radiopharmaceutical drug candidate, Samarium-153-DOTMP or CycloSam. The company was founded by Christopher M. Nelson, Douglas R. Baum and C. Richard Piazza on August 26, 2004 and is headquartered in Austin, TX. | Process Industries |
| Orsenix LLC | |
Vetigenics LLC
Vetigenics LLC Pharmaceuticals: MajorHealth Technology Vetigenics LLC is a clinical-stage animal health biopharmaceutical company based in Philadelphia, PA. Vetigenics LLC is committed to advancing targeted antibody therapies for pets using its proprietary canibody™ technology. Vetigenics' innovative technology and expertise in antibody discovery and development are trusted by animal health partners and the National Cancer Institute. Vetigenics is dedicated to enabling pets to live their best lives. The company was founded by Adriann W. Sax, Don Siegel, and Nicola Mason, with Adriann W. Sax serving as the CEO since incorporation. | Health Technology |
